tiprankstipranks
X4 Pharmaceuticals reports Q4 EPS (10c), consensus (15c)
PremiumThe FlyX4 Pharmaceuticals reports Q4 EPS (10c), consensus (15c)
28d ago
Options Volatility and Implied Earnings Moves This Week, March 18 – March 21, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 18 – March 21, 2024
1M ago
X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024
PremiumPress Releases
X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024
1M ago
B. Riley gets more bearish on X4 Pharmaceuticals, downgrades shares
PremiumThe FlyB. Riley gets more bearish on X4 Pharmaceuticals, downgrades shares
4M ago
X4 Pharmaceuticals presents additional data from Mavorixafor Phase 2 trial
PremiumThe Fly
X4 Pharmaceuticals presents additional data from Mavorixafor Phase 2 trial
4M ago
X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023
PremiumPress Releases
X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023
4M ago
X4 Pharmaceuticals to Report Third-Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 9, 2023
PremiumPress ReleasesX4 Pharmaceuticals to Report Third-Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 9, 2023
6M ago
X4 Pharmaceuticals (NASDAQ:XFOR) Surges With New FDA Priority Review
PremiumMarket News
X4 Pharmaceuticals (NASDAQ:XFOR) Surges With New FDA Priority Review
6M ago
X4 announces FDA acceptance with priority review of U.S. NDA for mavorixafor
PremiumThe Fly
X4 announces FDA acceptance with priority review of U.S. NDA for mavorixafor
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100